Recombinant mva viruses expressing clade a/g, clade b, and...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/16 (2006.01) A61K 39/21 (2006.01) C12N 15/863 (2006.01)

Patent

CA 2578403

The invention provides modified vaccinia Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes.

L'invention concerne un virus de la vaccine Ankara (MVA) modifiée, souche à déficience de réplication du virus de la vaccine, exprimant les gènes env, gag et pol du VIH.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant mva viruses expressing clade a/g, clade b, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant mva viruses expressing clade a/g, clade b, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant mva viruses expressing clade a/g, clade b, and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1853264

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.